Feb. 22 at 7:49 PM
🌅 4:00am EST Watchlist — February 22, 2026
$VNDA – FDA approved BYSANTI (milsaperidone) for schizophrenia + bipolar I disorder. Launch planned later in 2026; next watch is differentiation in a crowded antipsychotic market + any labeling and follow-up details that impact uptake. 💊🧠
$VHUB – Unveiled its Vision System upgrade: computer-vision automation for shelf calibration + real-time planograms on its Smart Store platform. Story is faster setup, less manual merchandising, and more responsive shelf layouts. 🤖🛒
Potential multi-day runners:
$CDIO ✅
$SGN ✅
$AXTI ✅